~22 months to genesis. Every phase named. Every dependency visible. No timeline that requires us to be lucky.
Phase A — Protocol modernization
Now → Q3 2026The inscription contract is written in Algorand Python (algopy) and uses the real native falcon_verify opcode. A reference implementation of the five inscription invariants exists and has been through internal multi-model review; the remaining work in this phase is compilation and on-chain test vectors, the founding-cryptographer review, and the TestNet dress rehearsal.
- Modern algopy contract feature-complete (done)
- Unit tests with mocked Falcon opcode (done)
- Deploy + mint + ceremony pipeline drafted (done)
- Internal threat-model pass (done — 27 May)
- TestNet end-to-end dress rehearsal (in progress — runbook drafted)
- Founding cryptographer engaged + Falcon path reviewed (outreach drafted; first three emails pending)
Phase B — Legal & capital foundation
Now → Q4 2026LEXR Zürich (Christian Meisser) is the lead counsel candidate — scoping completed, not yet engaged. The Stiftung forms in Zug under articles 80–89bis of the Swiss Civil Code, with ESA supervision at registration. Updated sequencing: a pre-LEXR specialist-consultation queue (cross-border tax · IP · GDPR · MiCA · Bpifrance acceptance · pre-formation operational funding) now precedes LEXR retention so the Stiftung statuten draft starts with all specialist inputs in hand. First capital lands via NLnet NGI0 / Filecoin Foundation / Algorand Foundation Accelerator Tier-2 (queued for next cohort) / F&F bridge / Sovereign Tech Fund / OSTIF — first arriving tranche funds the specialist queue. Swiss IGE trademark application 08601/2026 was filed 19 May 2026 and is pending registration; Madrid Protocol extension follows. Stiftungsrat target composition expanded to 3+ trustees pre-formation per BVS guidance.
- Swiss IGE trademark filed (done — 19 May)
- Pre-LEXR specialist consultations · 8 specialists, pre-formation operational funding (queue mapped — 27 May)
- Counsel selection — LEXR scoping completed (no engagement signed) (in progress — sequencing revised)
- A cryptographer at a leading European research institution (in selection) for Stiftungsrat seat 2 (outreach to independent cryptographers for external review is underway)
- Third Stiftungsrat seat secured (Swiss professional fiduciary via LEXR network) (planned Q3-Q4 2026)
- Stiftung incorporated in Zug with 3+ trustees (planned Q1-Q2 2027 post specialist queue)
- FINMA informal pre-formation guidance via LEXR network (planned during LEXR retention)
- Algorand Accelerator Tier-2 application submitted (packet built; waiting for next cohort opening)
- F&F bridge round opened (drafts ready)
EU jurisdictional unlock (27 May 2026): French-citizen founder + planned Munich research adjacency unlocks the Bpifrance suite (Bourse French Tech · BFTE · ADD DeepTech · NCC-FR PQC · French Tech 2030), German PrototypeFund, and strengthens EIC Accelerator (€2.5M + €5M investment) + HORIZON-CL3-2026-02-CS-ECCC (€1-2M) eligibility. This forms part of pre-formation operational funding.
Phase C — Cryptographer review & hardening
Q4 2026 → Q2 2027The founding cryptographer reviews the Falcon-1024 binding, the on-chain operand handling, and the divergence between the Algorand falcon_verify opcode implementation and the (still-in-development) FIPS 206 standard. The contingency memo (Position B and Position C) is reviewed against their input. The threat model is hardened against their findings.
- Founding cryptographer review of Falcon path (blocked on engagement)
- FIPS 206 contingency memo reviewed by cryptographer + LEXR
- Threat model updated
- Risk Register updated
Phase D — Formal audit
Q2 2027 → Q3 2027Third-party smart-contract audit. We are leading with Runtime Verification for the formal-methods fit on AVM v12 + algopy; a backup quote is being sourced in parallel. The audit firm produces severity-ranked findings, formal-methods proof of the five inscription invariants, full remediation cycle, and a public summary that we publish post-genesis.
- Audit firm RFQ issued (drafted — 27 May)
- Audit firm contracted
- Primary audit + remediation cycle
- Re-audit of Critical + High findings
- Contract frozen for pre-sale
Phase E — FINMA & compliance
Q2 2027 → Q3 2027FINMA pre-ruling on Cell classification (Nutzungstoken intent, conjunctive transferability lock, per-buyer cap). KYC/AML funnel integrated — Sumsub for identity + wallet screening, VerifyInvestor.com for US Reg D 506(c) accredited verification, ComplyAdvantage for ongoing sanctions/PEP screening. CH/EU/US/UK legal opinions delivered ahead of the Section 2 stop condition at 15 November 2027.
- FINMA pre-ruling response received
- KYC/AML vendors contracted + DPAs executed (decision memo done; sign-off pending)
- KYC funnel integrated into pre-sale portal
- CH/EU/US/UK legal opinions delivered
- SEC Form D filing readied
Phase F — Cell pipeline & treasury custody
Q3 2027All 1,024 Vault Cell artworks rendered, ARC-3 metadata pinned to IPFS via Pinata + a secondary pin provider for durability. Inscription contract pre-funded for box MBR (~46 ALGO across 1,024 cells). Cold key-generation ceremony executed with Shamir 5-share custody, geographically distributed. Warm Pera multisig provisioned. Cold-withdrawal dry run completed before pre-sale opens.
- 1,024 Cell artworks rendered + pinned
- Cold key ceremony executed
- Shamir share-holders named in writing
- Warm multisig provisioned
- Cold-withdrawal dry run completed
Phase G — Cell pre-sale
Q4 2027300 of the 1,024 Cells offered to participants who complete KYC/AML, sanctions screening, and (where applicable) US accredited-investor verification. Three tiers — Founding (USD 40,000 × 24), Pillar (USD 15,000 × 75), Vault (USD 8,000 × 201). Maximum two Cells per beneficial owner. Maximum aggregate raise ~ USD 3.69M. Conjunctive transferability lock: inscription required AND 24 months from genesis before transfer. Cell #1 is foundation reserve — inscribable, never transferable.
- Pre-sale opens (post-audit)
- Per-buyer due-diligence dossiers completed
- Settlement on Algorand (genesis targeted Q2 2028; currently TestNet)
- Cells distributed to buyers
Phase H — Genesis dress rehearsal
Q1 2028The full genesis sequence rehearsed end-to-end on TestNet with all attendees — founder, Stiftungsräte, founding cryptographer, engaged counsel, auditor representative, and an independent witness. The ceremony runbook is exercised verbatim. Any failure mode that surfaces in the rehearsal is addressed before genesis.
- Full attendee set rehearses sequence on TestNet
- Ceremony runbook revised on findings
- Recorded video produced + pinned to IPFS
Phase I — Genesis
Q2 2028The TRELYAN ASA and the 1,024 Vault Cells go live on Algorand (genesis targeted Q2 2028; currently TestNet) under the audited, cryptographer-reviewed inscription contract enforced by the native falcon_verify opcode (AVM v12 / consensus v41 / go-algorand v4.3.0). Cell #1 is inscribed at genesis with the Cell #1 Inscription Manifesto. Post-genesis validation script confirms the deployment. Public announcement coordinates with the major Algorand-ecosystem outlets under embargo.
- Deployment to Algorand
- Cell #1 inscribed
- Post-genesis validation
- Public release with embargo
TRELYAN Foundation (in formation) · Roadmap updated 27 May 2026 · No public offer · No invitation to invest · Not financial or legal advice